Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
FY24 RWHAP Part A Program Terms Report Manual
Instructions on how RWHAP Part A recipients on the RWHAP Part A PTR.Resource updated 04/03/2024
-
CQII Eliminating Disparities Due to Substance Use Issues - Core Interventions
Core interventions related to addressing substance use in order to eliminate disparities in viral suppression rates.Resource updated 09/14/2023
-
MORE: Mobile Outreach Prevention and Engagement
MORE focuses on people who are not virally suppressed and/or who have not attended an HIV medical appointment in six months. Participants can choose from one of three MORE programs, depending on the intensity of services they want. Based on initial evaluation findings, participants who received more intensive MORE services were more likely to be virally suppressed and less likely to be lost to follow-up than those who received less intensive services.Resource from the RWHAP Best Practices Compilation updated on 04/15/2024
-
How to Conduct Remote Subrecipient Site Visits
Best practices and tools for conducting effective remote subrecipient monitoring. Presentation from the HRSA HIV/AIDS Bureau Division of State HIV/AIDS Programs (DSHAP) Business Day Meeting at the 2022 RWC.Resource (Conference Presentation) updated 09/14/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
A Call for Enhanced Data Collection
The syndemic of opioid use disorder, HCV and HIV and stigma causes burdens on individuals and the system. Integrating siloed systems of care is critical to addressing this crisis. Overlapping cascades of care are key to understanding the empirical relationships of these diseases and opportunities to identify, prevent and co-treat.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Developing Electronic Clinical Quality Measures for HIV Care
Overview of HRSA HAB work to develop three electronic clinical quality measures (eCQMs) focused on HIV care.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
Non-Competing Continuation RWHAP Part B/ADAP (X07): FY24 NCC Progress Report Submission
Instructions and resources for completing and submitting the FY 2024 Ryan White HIV/AIDS Program (RWHAP) Part B Non-Competing Continuation Progress Report.Resource updated 10/10/2023
-
RWHAP Part C Allocations Report Manual
Instructions on how all Ryan White HIV/AIDS Program (RWHAP) Part C recipients can access, complete, and submit the RWHAP Part C Allocations Report.
Resource updated 06/27/2024
-
Homeless Health Outreach Mobile Engagement (HHOME)
HHOME offers mobile HIV primary care, behavioral health care, and connection to housing services to people with HIV experiencing homelessness. A centralized HHOME team acts as a hub to meet clients where they are, refer them to housing and support services, and provide ongoing case management and HIV primary care services. Clients participating in HHOME experienced increased retention in care, viral suppression, and connection to stable housing.Resource from the RWHAP Best Practices Compilation updated on 11/27/2023
-
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024
-
RWHAP Part A Expenditures Report Manual
Instructions on how RWHAP Part A recipients can access, complete, and submit the RWHAP Part A Expenditures Report.Resource updated 03/11/2024
-
Using Graphs to Analyze and Share Performance Data
Review of graphical tools for use in analysis and presentation of quality improvement data.Resource updated 10/31/2023
-
Enlaces Por La Salud
Enlaces Por La Salud is an HIV linkage, navigation, and education program for Mexican men and transgender women. The intervention is grounded in a transnational framework for providing cultural context to support the delivery of one-on-one educational sessions to Latina(o/x) people with a new HIV diagnosis, as well as people with HIV who are not yet retained in care. After 12 months, the majority of people participating in Enlaces Por La Salud were retained in care and reached viral suppression.Resource from the RWHAP Best Practices Compilation updated on 06/26/2024
-
Virginia Rapid Start Collaborative
Virginia Rapid Start launched with HIV care providers across the state with goals to initiate ART for clients within 14 days of HIV diagnosis and to improve access to, and retention in, high-quality HIV care and support services. Through Virginia Rapid Start, providers initiated ART medications within an average of four days of HIV diagnosis, as compared with the statewide average of 28 days. Virginia Rapid Start clients had higher rates of viral suppression compared to both the RWHAP Part B overall and Virginia overall. The success of Virginia Rapid Start led VDH to expand the program to the entire Virginia RWHAP Part B.Resource from the RWHAP Best Practices Compilation updated on 01/18/2024
-
Funding Opportunity: RWHAP Implementation for HIV Clinical Quality Improvement (HRSA-24-072)
This HRSA HIV/AIDS Bureau pre-application webinar was for the Notice of Funding Opportunity, Ryan White HIV/AIDS Program (RWHAP) Implementation for HIV Clinical Quality Improvement (HRSA-24-072).Resource updated 01/29/2024